Longevity Investors & VC Firms in Switzerland
13 firms in this list, with a median first check of $1.9M. 4 of them lead rounds. Generated from verified public data and updated continuously.
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
39 people
Unruly Capital
LondonPre-Seed–Series A
3 people
HealthCap
StockholmSeed–Growth
30 people
Apollo Health Ventures
BerlinSeed–Series A
32 people
Delin Ventures
LondonPre-Seed–Series A$216K – $2.2M
21 people
Maximon
ZugPre-Seed–Series A$11M
23 people
Kinled Holding
Hong KongSeed–Series A
1 person
Auriga Partners
ParisSeed–Growth$540K – $5.4M
15 people
Aescap Life Sciences
AmsterdamSeed–Growth
14 people
naturalX Health Ventures
KarlsruheSeed–Late Stage$3.2M – $5.4M
5 people
Exelixis Capital
Zürich
3 people
Reech Corporations Group
Dubai
10 people
Deep Knowledge Group
LondonSeed
7 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.





































